Abnormal alterations in PTPN5 activity are associated with several neurological disorders, and it is known that upregulation of PTPN5 may have a causal role in Alzheimer’s disease (Chin et al., 2005; Saavedra et al., 2011). The gene discussed is PTPN5; the disease is early-onset autosomal dominant Alzheimer disease.